全文获取类型
收费全文 | 37427篇 |
免费 | 3020篇 |
国内免费 | 172篇 |
专业分类
耳鼻咽喉 | 333篇 |
儿科学 | 1203篇 |
妇产科学 | 1254篇 |
基础医学 | 4689篇 |
口腔科学 | 623篇 |
临床医学 | 6079篇 |
内科学 | 6756篇 |
皮肤病学 | 524篇 |
神经病学 | 3291篇 |
特种医学 | 792篇 |
外科学 | 3631篇 |
综合类 | 704篇 |
现状与发展 | 1篇 |
一般理论 | 66篇 |
预防医学 | 4368篇 |
眼科学 | 531篇 |
药学 | 2523篇 |
4篇 | |
中国医学 | 219篇 |
肿瘤学 | 3028篇 |
出版年
2023年 | 253篇 |
2022年 | 364篇 |
2021年 | 770篇 |
2020年 | 598篇 |
2019年 | 990篇 |
2018年 | 1048篇 |
2017年 | 764篇 |
2016年 | 857篇 |
2015年 | 1034篇 |
2014年 | 1288篇 |
2013年 | 1939篇 |
2012年 | 2650篇 |
2011年 | 2779篇 |
2010年 | 1580篇 |
2009年 | 1380篇 |
2008年 | 2428篇 |
2007年 | 2515篇 |
2006年 | 2514篇 |
2005年 | 2388篇 |
2004年 | 2219篇 |
2003年 | 2067篇 |
2002年 | 1932篇 |
2001年 | 488篇 |
2000年 | 406篇 |
1999年 | 407篇 |
1998年 | 459篇 |
1997年 | 330篇 |
1996年 | 312篇 |
1995年 | 317篇 |
1994年 | 272篇 |
1993年 | 269篇 |
1992年 | 256篇 |
1991年 | 205篇 |
1990年 | 195篇 |
1989年 | 170篇 |
1988年 | 156篇 |
1987年 | 144篇 |
1986年 | 129篇 |
1985年 | 157篇 |
1984年 | 147篇 |
1983年 | 136篇 |
1982年 | 162篇 |
1981年 | 151篇 |
1980年 | 153篇 |
1979年 | 75篇 |
1978年 | 73篇 |
1977年 | 70篇 |
1976年 | 77篇 |
1975年 | 68篇 |
1974年 | 60篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
991.
992.
Lize Bollen Marijke Peetermans Miet Peeters Kristel Van Steen Marc F. Hoylaerts Paul J. Declerck Peter Verhamme Ann Gils 《Thrombosis research》2014
Background
Both activated Thrombin Activatable Fibrinolysis Inhibitor (TAFI) and active Plasminogen Activator Inhibitor-1 (PAI-1) attenuate fibrinolysis and may therefore contribute to the pathophysiology of Venous ThromboEmbolism (VTE). Whether increased TAFI and/or PAI-1 concentrations are associated with VTE is unclear.Objective
To study an association of impaired fibrinolysis and VTE using a comprehensive panel of in-house developed assays measuring intact TAFI, activation peptide of TAFI (AP-TAFI), PAI-1 antigen, endogenous PAI-1:t-PA complex (PAI-1:t-PA) and active PAI-1 levels in 102 VTE patients and in 113 healthy controls (HC).Results
Active PAI-1 was significantly higher in VTE patients compared to HC (20.9 [9.6-37.8] ng/ml vs. 6.2 [3.5-9.7] ng/ml, respectively). Active PAI-1 was the best discriminator with an area under the ROC curve and 95% confidence interval (AUROC [95%CI]) of 0.84 [0.79-0.90] compared to 0.75 [0.68-0.72] for PAI-1:t-PA, 0.65 [0.58-0.73] for PAI-1 antigen, 0.62 [0.54-0.69] for AP-TAFI and 0.51 [0.44-0.59] for intact TAFI. Using ROC analysis, we defined an optimal cut-off of 12.8 ng/ml for active PAI-1, with corresponding sensitivity of 71 [61–79] % and specificity of 89 [82–94] %. A lack of association with the time between VTE event and sample collection or with the intake of anticoagulant treatment suggests that active PAI-1 levels are sustainable high in VTE patients.Conclusions
This case–control study emphasizes the clinical importance of measuring active PAI-1 instead of PAI-1 antigen and identifies active PAI-1 as a potential marker of VTE. Prognostic studies will need to address the clinical significance of active PAI-1 as biomarker. 相似文献993.
Glycosaminoglycans (GAG) have diverse functions that regulate macromolecular assembly in the extracellular matrix. During pregnancy, the rigid cervix transforms to a pliable structure to allow birth. Quantitative assessment of cervical GAG is a prerequisite to identify GAG functions in term and preterm birth. In the current study, total GAG levels increased at term, yet the abundance, chain length, and sulfation levels of sulfated GAG remained constant. The increase in total GAG resulted exclusively from an increase in hyaluronan (HA). HA can form large structures that promote increased viscosity, hydration, and matrix disorganization as well as small structures that have roles in inflammation. HA levels increased from 19% of total GAG in early pregnancy to 71% at term. Activity of the HA-metabolizing enzyme, hyaluronidase, increased in labor, resulting in metabolism of large to small HA. Similar to mice, HA transitions from high to low molecular weight in term human cervix. Mouse preterm models were also characterized by an increase in HA resulting from differential expression of the HA synthase (Has) genes, with increased Has1 in preterm in contrast to Has2 induction at term. The Has2 gene but not Has1 is regulated in part by estrogen. These studies identify a shift in sulfated GAG dominance in the early pregnant cervix to HA dominance in term and preterm ripening. Increased HA synthesis along with hyaluronidase-induced changes in HA size in mice and women suggest diverse contributions of HA to macromolecular changes in the extracellular matrix, resulting in loss of tensile strength during parturition. 相似文献
994.
995.
996.
HH Chang YM Huang CP Wu YC Tang CW Liu CH Huang LT Ho LY Wu YC Kuo YH Kao 《General and comparative endocrinology》2012,178(3):450-458
Endothelin (ET)-1 and suppressor of cytokine signaling (SOCS)-3 were respectively found to regulate energy metabolism and hormone signaling in fat cells. Although ET-1 can also regulate the expression of SOCS-3-stimulating hormones, it is still unknown whether ET-1 regulates SOCS-3 gene expression. This study investigated the pathways involved in ET-1's modulation of SOCS-3 gene expression in 3T3-L1 adipocytes. ET-1 upregulated SOCS-3 mRNA and protein expression in dose- and time-dependent manners. The concentration of ET-1 that increased SOCS-3 mRNA levels by 250-400% was ~100nM with 2-4h of treatment. Treatment with actinomycin D prevented ET-1-stimulated SOCS-3 mRNA expression, suggesting that the effect of ET-1 requires new mRNA synthesis. Pretreatment with the ET type A receptor (ET(A)R) antagonist, BQ-610, but not the ET type B receptor (ET(B)R) antagonist, BQ-788, prevented the stimulatory effect of ET-1 on SOCS-3 gene expression. The specific inhibitors of either MEK1 (U-0126 and PD-98059), JAK (AG-490), JNK (SP-600125), or PI3K (LY-294002 and wortmannin) reduced ET-1-increased levels of SOCS-3 mRNA and respectively inhibited ET-1-stimulated activities of MEK1, JAK, JNK, and PI3K. These results imply that the ET(A)R, ERK, JAK, JNK, and PI3K are functionally necessary for ET-1's stimulation of SOCS-3 gene expression. Moreover, ET-1 was observed to upregulate expressions of SOCS-1, -2, -3, -4, -5, and -6 mRNAs, but not SOCS-7 or cytokine-inducible SH2-containing protein-1 mRNAs. This suggests that ET-1 selectively affects particular types of SOCS family members. Changes in SOCS gene expressions induced by ET-1 may help explain the mechanism by which ET-1 modulates hormone signaling of adipocytes. 相似文献
997.
998.
Zhu B Shrivastava A Luongo C Chen T Harney JW Marsili A Tran TV Bhadouria A Mopala R Steen AI Larsen PR Zavacki AM 《The Journal of endocrinology》2012,214(1):87-94
Previously, it was shown that the type 1 deiodinase (D1) is subject to substrate-dependent inactivation that is blocked by pretreatment with the inhibitor of D1 catalysis, propylthiouracil (PTU). Using HepG2 cells with endogenous D1 activity, we found that while considerable D1-mediated catalysis of reverse tri-iodothyronine (rT(3)) is observed in intact cells, there was a significant loss of D1 activity in sonicates assayed from the same cells in parallel. This rT(3)-mediated loss of D1 activity occurs despite no change in D1 mRNA levels and is blocked by PTU treatment, suggesting a requirement for catalysis. Endogenous D1 activity in sonicates was inactivated in a dose-dependent manner in HepG2 cells, with a ~50% decrease after 10?nM rT(3) treatment. Inactivation of D1 was rapid, occurring after only half an hour of rT(3) treatment. D1 expressed in HEK293 cells was inactivated by rT(3) in a similar manner. (75)Se labeling of the D1 selenoprotein indicated that after 4?h rT(3)-mediated inactivation of D1 occurs without a corresponding decrease in D1 protein levels, though rT(3) treatment causes a loss of D1 protein after 8-24?h. Bioluminescence resonance energy transfer studies indicate that rT(3) exposure increases energy transfer between the D1 homodimer subunits, and this was lost when the active site of D1 was mutated to alanine, suggesting that a post-catalytic structural change in the D1 homodimer could cause enzyme inactivation. Thus, both D1 and type 2 deiodinase are subject to catalysis-induced loss of activity although their inactivation occurs via very different mechanisms. 相似文献
999.
1000.